Potassium channels on smooth muscle as a molecular target for plant-derived Resveratrol.
暂无分享,去创建一个
J. Sharifi‐Rad | M. Martorell | J. Rajkovic | L. Gojkovic-Bukarica | R. Novakovic | M. Gostimirovic | V. Djokic | L. Gojković-Bukarica | J. Rajković | R. Novaković | Javad Sharifi‐Rad
[1] B. Salehi,et al. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases , 2020, Journal of clinical medicine.
[2] Peng Ye,et al. Potassium Channels in the Vascular Diseases , 2018, Vascular Biology - Selection of Mechanisms and Clinical Applications.
[3] J. Rajkovic,et al. Effect of gestational diabetes mellitus and pregnancy-induced hypertension on human umbilical vein smooth muscle KATP channels. , 2019, Experimental and molecular pathology.
[4] S. Leung,et al. Vascular adenosine monophosphate‐activated protein kinase: Enhancer, brake or both? , 2019, Basic & Clinical Pharmacology & Toxicology.
[5] O. Yildiz,et al. Potassium channels in vascular smooth muscle: a pathophysiological and pharmacological perspective , 2019, Fundamental & clinical pharmacology.
[6] J. Rajkovic,et al. The red wine polyphenol resveratrol induced relaxation of the isolated renal artery of diabetic rats: The role of potassium channels , 2019, Journal of Functional Foods.
[7] A. Mishra,et al. Resveratrol: A Double-Edged Sword in Health Benefits , 2018, Biomedicines.
[8] Shu-Leei Tey,et al. Mechanism of resveratrol-induced relaxation of the guinea pig fundus. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[9] F. Lasitschka,et al. Role of ATP-sensitive potassium channels on hypoxic pulmonary vasoconstriction in endotoxemia , 2018, Respiratory Research.
[10] Qianyun Feng,et al. Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications , 2018, Bioscience reports.
[11] N. Tsoukias,et al. The yin and yang of KV channels in cerebral small vessel pathologies , 2018, Microcirculation.
[12] Xiaoping Lei,et al. Resveratrol as a potential therapeutic drug for respiratory system diseases , 2017, Drug design, development and therapy.
[13] I. Milosavljević,et al. The red wine polyphenol, resveratrol improves hemodynamics, oxidative defence and aortal structure in essential and malignant hypertension , 2017 .
[14] E. Nalivaiko,et al. Resveratrol restores uterine contractions during hypoxia by blockade of ATP-sensitive potassium channels , 2017 .
[15] Tuong-Vi Nguyen,et al. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment , 2017, Scientific Reports.
[16] Shu-Leei Tey,et al. Mechanism of resveratrol-induced relaxation in the human gallbladder , 2017, BMC Complementary and Alternative Medicine.
[17] N. Tykocki,et al. Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles. , 2017, Comprehensive Physiology.
[18] D. Warburton,et al. Inhaled resveratrol treatments slow ageing-related degenerative changes in mouse lung , 2017, Thorax.
[19] Leonard K. Kaczmarek,et al. International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels , 2017, Pharmacological Reviews.
[20] H. Uzun,et al. Endothelial Dysfunction and Hypertension. , 2016, Advances in experimental medicine and biology.
[21] Wen-Xie Xu,et al. Regulation of myometrial contraction by ATP-sensitive potassium (KATP) channel via activation of SUR2B and Kir 6.2 in mouse , 2016, The Journal of veterinary medical science.
[22] Hussein N. Rubaiy. The therapeutic agents that target ATP-sensitive potassium channels , 2016, Acta pharmaceutica.
[23] Haixia Huang,et al. Advanced Glycation End Products Impair Voltage-Gated K+ Channels-Mediated Coronary Vasodilation in Diabetic Rats , 2015, PloS one.
[24] Chung-Pin Li,et al. High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults , 2015, Medicine.
[25] N. Weissmann,et al. Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction , 2015, European Respiratory Journal.
[26] V. Schini-Kerth,et al. Role of AMP-activated Protein Kinase in NO- and EDHF-mediated Endothelium-dependent Relaxations to Red Wine Polyphenols. , 2015, Indian journal of physiology and pharmacology.
[27] T. Gudermann,et al. AMPK Dilates Resistance Arteries via Activation of SERCA and BKCa Channels in Smooth Muscle , 2015, Hypertension.
[28] B. Ivković,et al. Effects of the polyphenol resveratrol on contractility of human term pregnant myometrium. , 2015, Molecular human reproduction.
[29] N. MacAulay,et al. PKC and AMPK regulation of Kv1.5 potassium channels , 2015, Channels.
[30] L. Gojkovic-Bukarica,et al. The Role of Potassium Channels in the Vasodilatation Induced by Resveratrol and Naringenin in Isolated Human Umbilical Vein , 2015, Drug development research.
[31] Li-xue Zhang,et al. Resveratrol and genistein inhibition of rat isolated gastrointestinal contractions and related mechanisms. , 2014, World journal of gastroenterology.
[32] P. Koulen,et al. Resveratrol and Calcium Signaling: Molecular Mechanisms and Clinical Relevance , 2014, Molecules.
[33] W. Beierwaltes,et al. Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging. , 2014, American journal of physiology. Renal physiology.
[34] A. Fenning,et al. Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues from Young Rats , 2014, Advances in pharmacological sciences.
[35] S. Dalaklıoğlu,et al. Role of different types of potassium channels in the relaxation of corpus cavernosum induced by resveratrol , 2014, Pharmacognosy magazine.
[36] R. Novakovic,et al. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[37] R. Novakovic,et al. Cardiovascular effects of resveratrol. , 2013, Vojnosanitetski Pregled.
[38] C. Sena,et al. Endothelial dysfunction - a major mediator of diabetic vascular disease. , 2013, Biochimica et biophysica acta.
[39] R. Novakovic,et al. Effect of Wine Polyphenol Resveratrol on the Contractions Elicited Electrically or by Norepinephrine in the Rat Portal Vein , 2013, Phytotherapy Research.
[40] K. Thakali,et al. Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches. , 2013, Pharmacological research.
[41] A. Jovanovic,et al. KATP channels are up-regulated with increasing age in human myometrium , 2013, Mechanisms of Ageing and Development.
[42] J. Carvalho-de-Souza,et al. BK Channels in Cardiovascular Diseases and Aging. , 2013, Aging and disease.
[43] M. Shen,et al. The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms. , 2013, Vascular pharmacology.
[44] F. Lang,et al. Downregulation of Kv1.5 K+ Channels by the AMP-Activated Protein Kinase , 2012, Cellular Physiology and Biochemistry.
[45] B. Thjódleifsson,et al. Natural History of Irritable Bowel Syndrome in Women and Dysmenorrhea: A 10-Year Follow-Up Study , 2012, Gastroenterology research and practice.
[46] Chun Jiang,et al. K(ATP) channel action in vascular tone regulation: from genetics to diseases. , 2012, Sheng li xue bao : [Acta physiologica Sinica].
[47] U. Förstermann,et al. Cardiovascular effects and molecular targets of resveratrol. , 2012, Nitric oxide : biology and chemistry.
[48] S. Olesen,et al. AMP‐Activated Protein Kinase Downregulates Kv7.1 Cell Surface Expression , 2012, Traffic.
[49] F. Lang,et al. Downregulation of Kv 1 . 5 K + Channels by the AMP-Activated Protein Kinase , 2012 .
[50] A. Mori,et al. Resveratrol prevents bradykinin-induced contraction of rat urinary bladders by decreasing prostaglandin production and calcium influx. , 2011, European journal of pharmacology.
[51] N. Holstein-Rathlou,et al. Closure of multiple types of K+ channels is necessary to induce changes in renal vascular resistance in vivo in rats , 2011, Pflügers Archiv - European Journal of Physiology.
[52] B. Kemp,et al. Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase. , 2011, Biochemical and biophysical research communications.
[53] Kai-Lee Wang,et al. Effects of resveratrol, a grape polyphenol, on uterine contraction and Ca²+ mobilization in rats in vivo and in vitro. , 2011, Endocrinology.
[54] Karen Brown,et al. Clinical trials of resveratrol , 2011, Annals of the New York Academy of Sciences.
[55] K. Dharmashankar,et al. Vascular Endothelial Function and Hypertension: Insights and Directions , 2010, Current hypertension reports.
[56] A. Mathie,et al. SYMPOSIUM REVIEW: Gating of two pore domain potassium channels , 2010, The Journal of physiology.
[57] Jin Han,et al. Pathophysiology of voltage-gated K+ channels in vascular smooth muscle cells: modulation by protein kinases. , 2010, Progress in biophysics and molecular biology.
[58] T. Flagg,et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. , 2010, Physiological reviews.
[59] D. Sept,et al. An Epilepsy/Dyskinesia-Associated Mutation Enhances BK Channel Activation by Potentiating Ca2+ Sensing , 2010, Neuron.
[60] Péter Enyedi,et al. Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .
[61] Kazuharu Furutani,et al. Inwardly rectifying potassium channels: their structure, function, and physiological roles. , 2010, Physiological reviews.
[62] Michel Félétou,et al. EDHF: an update. , 2009, Clinical science.
[63] S. Dkhar,et al. Potassium channels in health, disease & development of channel modulators. , 2009, The Indian journal of medical research.
[64] C. Nichols,et al. Molecular biology of KATP channels and implications for health and disease , 2009, IUBMB life.
[65] J. Cui,et al. Molecular mechanisms of BK channel activation , 2009, Cellular and Molecular Life Sciences.
[66] M. Bumbasirevic,et al. A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. , 2008, Journal of pharmacological sciences.
[67] Hongfang Li,et al. Inhibitory effects of genistein and resveratrol on guinea pig gallbladder contractility in vitro. , 2008, World journal of gastroenterology.
[68] Aaron Schindeler,et al. Seminars in cell & developmental biology. , 2008, Seminars in cell & developmental biology.
[69] R. Warth,et al. Physiology and pathophysiology of potassium channels in gastrointestinal epithelia. , 2008, Physiological reviews.
[70] L. Pirola,et al. Resveratrol: One molecule, many targets , 2008, IUBMB life.
[71] B. Aggarwal,et al. Resveratrol: A multitargeted agent for age-associated chronic diseases , 2008, Cell cycle.
[72] L. Kuo,et al. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. , 2007, Investigative ophthalmology & visual science.
[73] R. Novakovic,et al. The effect of potassium channel opener pinacidil on the non-pregnant rat uterus. , 2007, Basic & Clinical Pharmacology & Toxicology.
[74] L. Chuang,et al. Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. , 2007, European journal of pharmacology.
[75] V. Korovkina,et al. Potassium channels and uterine function. , 2007, Seminars in cell & developmental biology.
[76] B. Viollet,et al. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. , 2007, The Journal of physiology.
[77] C. Carlotti,et al. Endothelium dysfunction caused by acute pressure distension of human saphenous vein used for myocardial revascularization. , 2007, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.
[78] M. Breschi,et al. Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.
[79] A. Novaković,et al. Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol. , 2006, Basic & clinical pharmacology & toxicology.
[80] N. Teramoto. Physiological roles of ATP‐sensitive K+ channels in smooth muscle , 2006, The Journal of physiology.
[81] E. Demirel‐Yilmaz,et al. Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. , 2006, Vascular pharmacology.
[82] S. Aşlamacı,et al. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. , 2005, International journal of cardiology.
[83] A. Terzic,et al. K(ATP) channel therapeutics at the bedside. , 2005, Journal of molecular and cellular cardiology.
[84] R. Aldrich,et al. International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels , 2005, Pharmacological Reviews.
[85] Ivano Morelli,et al. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[86] L. Santana,et al. Downregulation of the BK Channel &bgr;1 Subunit in Genetic Hypertension , 2003, Circulation research.
[87] F. Ashcroft,et al. Potassium channel regulation , 2003, EMBO reports.
[88] G. Saade,et al. Effects of L-type Ca(2+)-channel blockade, K(+)(ATP)-channel opening and nitric oxide on human uterine contractility in relation to gestational age and labour. , 2003, Molecular human reproduction.
[89] K. Magleby,et al. Slo1 Tail Domains, but Not the Ca2+ Bowl, Are Required for the β1 Subunit to Increase the Apparent Ca2+ Sensitivity of BK Channels , 2002, The Journal of general physiology.
[90] J. Morrison,et al. Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. , 2002, Molecular human reproduction.
[91] U. Förstermann,et al. Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase , 2002, Circulation.
[92] Richard W. Aldrich,et al. Coupling between Voltage Sensor Activation, Ca2+ Binding and Channel Opening in Large Conductance (BK) Potassium Channels , 2002, The Journal of general physiology.
[93] E. Roche,et al. Nuclear KATP channels trigger nuclear Ca2+ transients that modulate nuclear function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[94] V. Korovkina,et al. Molecular Diversity Of Vascular Potassium Channel Isoforms , 2002, Clinical and experimental pharmacology & physiology.
[95] A. El-Mowafy. Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. , 2002, Biochemical and biophysical research communications.
[96] J. Leiro,et al. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. , 2002, Molecular pharmacology.
[97] Yongge Liu,et al. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. , 2001, Molecular pharmacology.
[98] E. Naderali,et al. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. , 2001, Clinical science.
[99] Christopher Miller. An overview of the potassium channel family , 2000, Genome Biology.
[100] F. Vogalis. Potassium channels in gastrointestinal smooth muscle. , 2000, Journal of autonomic pharmacology.
[101] P. Pagel,et al. Sarcolemmal and Mitochondrial Adenosine Triphosphate– dependent Potassium Channels: Mechanism of Desflurane-induced Cardioprotection , 2000, Anesthesiology.
[102] S. Chen,et al. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+ current in vascular endothelial cells. , 2000, Cardiovascular research.
[103] Y. Kurachi,et al. Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. , 2000, Pharmacology & therapeutics.
[104] W. Jackson. Ion channels and vascular tone. , 2000, Hypertension.
[105] E. Chien,et al. Expression of adenosine triphosphate-sensitive potassium channel subunits in female rat reproductive tissues: overlapping distribution of messenger ribonucleic acid for weak inwardly rectifying potassium channel subunit 6.1 and sulfonylurea-binding regulatory subunit 2. , 1999, American journal of obstetrics and gynecology.
[106] F. Rosenfeldt,et al. Pharmacology of coronary artery bypass grafts. , 1999, The Annals of thoracic surgery.
[107] E. Aiello,et al. Role of a Ca2+-activated K+ current in the maintenance of resting membrane potential of isolated, human, saphenous vein smooth muscle cells , 1999, Pflügers Archiv.
[108] N. Rusch,et al. Increased expression of Ca2+-sensitive K+ channels in aorta of hypertensive rats. , 1997, Hypertension.
[109] J. Monsuez,et al. Cardiac potassium currents and channels--part I: basic science aspects. , 1997, International journal of cardiology.
[110] N. Standen,et al. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. , 1997, Physiological reviews.
[111] S. Archer,et al. Potassium channel diversity in vascular smooth muscle cells. , 1997, Canadian journal of physiology and pharmacology.
[112] J. Martens,et al. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension. , 1996, Circulation research.
[113] C. Pace-Asciak,et al. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. , 1996, General pharmacology.
[114] F. Ashcroft,et al. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels , 1996, Nature.
[115] M. Nelson,et al. Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.
[116] M. Kotlikoff,et al. Role of G proteins and KCa channels in the muscarinic and beta-adrenergic regulation of airway smooth muscle. , 1995, The American journal of physiology.
[117] N. Standen,et al. KATP channels in vascular smooth muscle. , 1994, Cardiovascular research.
[118] N. Rusch,et al. Remission of high blood pressure reverses arterial potassium channel alterations. , 1994, Hypertension.
[119] S. Renaud,et al. Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.
[120] N. Standen,et al. Role of potassium channels in the vascular response to endogenous and pharmacological vasodilators. , 1991, Blood vessels.
[121] Y. Nishizuka. Studies and perspectives of protein kinase C. , 1986, Science.
[122] J P Cazenave,et al. The effects of flavonoids on cyclic nucleotide phosphodiesterases. , 1986, Progress in clinical and biological research.
[123] B. S. Pallotta. Calcium‐activated potassium channels in rat muscle inactivate from a short‐duration open state. , 1985, The Journal of physiology.
[124] K. Johnson. An Update. , 1984, Journal of food protection.
[125] A. Noma,et al. ATP-regulated K+ channels in cardiac muscle , 1983, Nature.
[126] R. Keynes. The ionic channels in excitable membranes. , 1975, Ciba Foundation symposium.